Human telomeres and adjacent subtelomeres are packaged as heterochromatin. Subtelomeric DNA undergoes methylation during development by DNA methyltransferase 3B (DNMT3B), including the CpG-rich promoters of the long non-coding RNA (TERRA) embedded in these regions. The factors that direct DNMT3B methylation to human subtelomeres and maintain this methylation throughout lifetime are yet unknown. The importance of subtelomeric methylation is manifested through the abnormal telomeric phenotype in Immunodeficiency, Centromeric instability and Facial anomalies (ICF) syndrome type 1 patients carrying mutations in DNMT3B. Patient cells demonstrate subtelomeric hypomethylation, accompanied by elevated TERRA transcription, accelerated telomere shortening and premature senescence of fibroblasts. ICF syndrome can arise due to mutations in at least three additional genes, ZBTB24 (ICF2), CDCA7 (ICF3) and HELLS (ICF4). While pericentromeric repeat hypomethylation is evident in all ICF syndrome subtypes, the status of subtelomeric DNA methylation had not been described for patients of subtypes 2-4. Here we explored the telomeric phenotype in cells derived from ICF2-4 patients with the aim to determine whether ZBTB24, CDCA7 and HELLS also play a role in establishing and/or maintaining human subtelomeric methylation. We found normal subtelomeric methylation in ICF2-4 and accordingly low TERRA levels and unperturbed telomere length. Moreover, depleting the ICF2-4-related proteins in normal fibroblasts did not influence subtelomeric methylation. Thus, these gene products are not involved in establishing or maintaining subtelomeric methylation. Our findings indicate that human subtelomeric heterochromatin has specialized methylation regulation and highlight the telomeric phenotype as a characteristic that distinguishes ICF1 from ICF2-4. ‡ Shir Toubiana, http://orcid.org/0000-0003-3001-5281.
Introduction
Telomeres are DNA/RNA/protein complexes present at chromosome extremities (1) with mammalian telomeric DNA composed of the hexameric repeat TTAGGG. Telomeres protect chromosome ends from digestion and breakage (2) . Normal human telomere length varies between 5 and 15 kb, depending on the age of the individual. Telomeres shorten every cell cycle due, in part, to the end replication problem (2) , and shortening to 3-5 kb triggers replicative senescence (3) . Telomeric regions in animal cells are characterized by heterochromatin-associated histone modifications (4, 5) and the human CpG-rich subtelomeres, positioned immediately adjacent to telomeres, are extensively methylated (6, 7) . Despite their heterochromatic nature, telomeric regions have the potential to transcribe telomeric repeat-containing RNA (TERRA), a long non-coding RNA produced by RNA polymerase II (8, 9) . Most TERRA transcripts initiate within close proximity to the telomere tract, and utilize the telomeric C-rich leading strand as their template (7, 10) . Various roles are attributed to TERRA, such as heterochromatinization, regulation of telomere length and telomere replication (11) (12) (13) (14) .
Subtelomeres undergo DNA methylation during early development by the de novo DNA methyltransferase 3B (DNMT3B), also known to preferentially methylate pericentromeric repeats in mouse and human (15) . The crucial role that subtelomeric methylation plays in human telomeric function and maintenance can be inferred from the abnormal telomeric phenotype that arises when DNMT3B is mutated (16, 17) . Mutations in DNMT3B are responsible for 55% of the Immunodeficiency, Centromeric instability and Facial anomalies (ICF) syndrome cases (18) . ICF syndrome is a rare autosomal recessive disease characterized by primary immunodeficiency and characteristic facial anomalies (19, 20) . At the molecular level, all ICF syndrome patients exhibit reduced DNA methylation at various genomic regions. Hypomethylation is most striking at pericentromeric heterochromatin blocks that form on tandem repetitive sequences such as satellite 2 and 3 repeats, which consequently fail to condense properly in mitosis (21, 22) . This decondensation leads to the typical centromeric instability and rearrangements of chromosomes 1, 9 and 16 (19) . In addition to pericentromeric heterochromatin, DNA methylation abnormalities were described in the telomeric heterochromatin regions in ICF type I (DNMT3B-mutated) cells. CpG sites in subtelomeres of ICF1 fibroblasts and lymphoblastoid cells (LCLs) are extensively hypomethylated, and this epigenetic disturbance is associated with abnormally short telomeres and elevated levels of TERRA transcription (16, 17) . Due to the short telomere phenotype, ICF1 fibroblasts enter senescence at a very low population doubling (PD) (23) . The abundant TERRA transcription results in elevated telomeric DNA:RNA hybrid levels, which are proposed to be a major force in telomere shortening in ICF1 (24) .
The high TERRA levels in ICF1 syndrome result from hypomethylation of the TERRA promoters that are embedded in the subtelomeric regions (16, 17) . TERRA promoters display typical characteristics of CpG islands (7) . Despite this fact, they undergo extensive methylation during embryonic development, in contrast to the majority of CpG islands that are protected at this stage from de novo methylation [reviewed in (25, 26) ]. The exact factors that direct DNMT3B-mediated methylation at human subtelomeres and maintain this methylation throughout lifetime are yet unknown.
In addition to DNMT3B, mutations in at least three other genes lead to ICF syndrome: zinc-finger and BTB domain containing 24 (ZBTB24; ICF2), cell division cycle associated 7 (CDCA7; ICF3) and Helicase, lymphoid-specific (HELLS, also known as LSH and PASG; ICF4) (18, 27, 28) . Further genetic heterogeneity exists since several ICF patients do not carry mutations in any of these four genes. ZBTB24 and CDCA7 are involved in the development of the hematopoietic lineage (29, 30) . ZBTB24 is a member of the POK/ZBTB family of transcription factors that plays important roles in lymphoid development (29) . CDCA7 is a Notch target involved in hematopoietic stem cell emergence (30) , and has been found to serve as a cofactor to c-MYC (31) . Importantly, it was reported that ZBTB24 positively controls CDCA7 expression (32) . Besides DNMT3B, HELLS is the only additional ICF gene that was clearly shown to be involved in establishing and maintaining DNA methylation in mice. HELLS is a member of the SNF2 chromatin remodeling protein family and is involved in both establishment and maintenance of methylation in pericentromeric and other repetitive regions (33) (34) (35) . Recently, CDCA7 and HELLS were shown to function as a chromatin remodeling complex in which CDCA7 both recruits HELLS to chromatin, as well as stimulates the ATPase activity of the complex (36) . While Hells mutant mice were shown to display subtelomeric hypomethylation (33) , the subtelomeric methylation status and the telomeric phenotype of ICF2-4 patients have not been reported.
The discovery of additional genes responsible for other ICF subtypes prompted us to explore whether in addition to centromeric and pericentromeric regions, these gene products play a role in establishing and/or maintaining human subtelomeric DNA methylation, and therefore when mutated would lead to telomeric abnormalities as in ICF1 (16, 17) . To this end, we studied subtelomeric methylation patterns and additional telomeric characteristics in different cell types of several ICF2-4 patients. Our findings indicate that in contrast to ICF1, the subtelomeric methylation patterns in cells of ICF2-4 patients do not differ significantly from those in normal cells, and ICF2-4 cells exhibit a normal telomeric phenotype. Accordingly, we show that knocking down the expression of ZBTB24, CDCA7 and HELLS in normal human fibroblasts does not affect subtelomeric methylation. Thus, we conclude that in contrast to pericentromeric repeats, ZBTB24, CDCA7 and HELLS are dispensable for establishment and maintenance of subtelomeric DNA methylation. Our results further suggest that subtelomeric methylation can serve as a molecular marker that distinguishes ICF1 from the remaining subtypes of this syndrome.
Results

Subtelomeric regions are methylated in ICF2-4 cells
The analysis of ICF2-4 patients included three ICF2 patients (two of them brothers; 2V and 2D), two ICF3 patients and one ICF4 patient (Table 1) . Patient samples were coded by a number describing the subtype of ICF followed by a letter designating the specific patient. We initiated our methylation analysis by confirming that ICF patients and control LCLs exhibit the expected methylation levels at centromeric and pericentromeric repeats. This validation was carried out since DNA methylation was demonstrated to be unstable in LCLs, with repetitive regions especially at risk of undergoing hypomethylation during prolonged culturing (37) . Four families of repetitive sequences were examined: satellites 2 and 3, NBL1 and α-satellite (Fig.  S1 ). As previously shown (27, 38, 39) , abnormal hypomethylation was observed for satellites 2 and 3 in all patient cells, including whole blood (WB), LCLs and fibroblasts. On the other hand, α-satellite was hypomethylated only in ICF2-4 samples, while ICF1 LCLs demonstrated the expected high methylation of this (17) . Arrows point to hybridization bands that appear in Sau3AI-digested samples only when these repeats are hypomethylated.
Patient samples were coded by a number describing the subtype of ICF, followed by a letter designating the specific patient. WT samples were coded by 'W' following a number designating the specific WT individual (see Tables 1 and 2 for description of all samples). Hypomethylated samples include ICF1 LCL (1C) and ICF1 fibroblasts (1W). All ICF2-4 LCLs (2V, 2D, 2Z, 3C and 4U), ICF3 fibroblasts (3S) and control LCLs (W1) are methylated, as indicated by the complete absence of the diagnostic bands in the Sau3AI lanes.
family of repeats. NBL-1 repeats were previously mapped to human subtelomeres (40) , although decoding of the human genome revealed that these repeats are actually located mainly at centromeric regions of acrocentric chromosomes. NBL-1 repeats were shown to be extremely hypomethylated in ICF1 LCLs and fibroblasts in comparison to control cells (17, 23) . Here we found that all four ICF subtypes demonstrated a similar NBL-1 hypomethylated pattern, both in LCLs and in fibroblasts ( Fig. S1C and E). Altogether, we concluded that our samples show the expected methylation patterns at centromeric and pericentromeric sequences. We next proceeded to examine whether subtelomeric regions are hypomethylated in ICF2-4 similarly to ICF1. We first analyzed the methylation status of the human subtelomeric repetitive sequence, Hutel, which is part of many TERRA promoters. Most TERRA promoters contain three repetitive DNA tracts, the '61-29-37 repeats' (7, 41) and the Hutel probe (42) overlaps mainly with the 61-base pair (bp) repeats and partially with the 29-bp repeats (Fig. 1A ). Southern analysis with the Hutel probe revealed that subtelomeres are methylated in ICF2-4 LCLs and fibroblasts in contrast to ICF1 LCLs and fibroblasts, (Fig. 1B) . This suggests that subtelomeric hypomethylation, at least at TERRA promotercontaining subtelomeres, is specific for ICF1.
By homology search between the Hutel sequence (42) and the described human subtelomeric sequences (43) we could conclude that this probe hybridizes to 20 subtelomeres with 74-100% homology, depending on the subtelomere (the sequence of acrocentric subtelomeres is not available yet). Therefore, the analysis using the Hutel probe provided information on the methylation status of all these subtelomeres collectively. In order to obtain a comprehensive view of methylation at specific subtelomeres, we carried out bisulfite analysis for five amplicons that represent seven subtelomeric regions, in WBs and LCLs ( Fig. 2A and B ) and for six amplicons that represent nine subtelomeric regions, in fibroblasts (Fig. 2C) . The data obtained for ICF2-4 LCLs and fibroblasts was compared with data either obtained previously for control and ICF1 LCLs or fibroblasts (44, 45) , or with the newly obtained data in this study. This comparison indicated that while subtelomeres in ICF1 WB and LCLs demonstrated a significant decrease in methylation levels compared with WT samples, ICF2-4 WBs and LCLs showed methylation levels very similar to those of control WB and LCLs (Figs. 2A, B and S2A, B). Similarly, subtelomeric methylation in ICF1 fibroblasts was also significantly low compared to WT fibroblasts, while ICF3 fibroblasts, did not differ significantly from the WT samples (Figs. 3C and S2C) (for ICF2 and 4 we had no fibroblast sample). Intriguingly, subtelomere 5p, in contrast to the other analyzed subtelomeres, showed partial hypomethylation in ICF3 fibroblasts ( Fig. S2C and D), although it was more methylated than in ICF1 fibroblasts.
Pearson correlation analysis of methylation patterns at subtelomeric regions indicated that ICF2-4 and control WB samples cluster together and are distinctly separated from ICF1 samples (Fig. 2D, left panel) . The same analysis performed on LCLs and fibroblasts showed similar clustering (Fig. 2D , middle and right panels). Hierarchical clustering of all samples subjected to bisulfite analysis, with each subtelomeric region compared across all samples, further highlighted the similarity in the subtelomeric methylation status between control and ICF2-4 samples (Fig. 2E ). In summary, we can conclude from these methylation analyses that mutations in ZBTB24, CDCA7 or HELLS do not globally disrupt normal human subtelomeric methylation patterns.
ICF2-4 cells express normal levels of the telomeric long non-coding RNA, TERRA
While the normal methylation pattern appeared to be consistent for the great majority of tested subtelomeres, we still could not dismiss the possibility that methylation of untested subtelomeric regions is affected by mutations in ZBTB24, CDCA7 and HELLS. We therefore inspected the telomeric phenotype in ICF2-4 cells by additional criteria. One of the striking consequences of subtelomeric hypomethylation in ICF1 is the significant elevation of TERRA expression (16, 17, 24) . We therefore determined the levels of TERRA originating from seven different telomeres, including four for which we had not determined subtelomeric methylation levels (8p, 10p, 16p and 19p), in LCLs of all ICF subtypes compared to control LCLs (Fig. 3A) . TERRA levels in ICF2-4 LCLs were not significantly different compared to levels in WT LCLs (Fig. S3 and A) . However, as shown previously, TERRA levels were significantly higher in ICF1 LCLs in five out of the seven examined telomeres in comparison to WT LCLs (24) , as well as when compared to each of the other ICF subtypes (P-value < 0.05, Welch's unequal variances t-test, Fig. S3A ). Telomeres 8p and 16p, whose levels of TERRA did not differ significantly between ICF1 and the remaining ) and subjected to qRT-PCR in at least two experimental repeats. For each telomere, TERRA expression in W1 was set at 1 and all other expression levels were determined relative to this sample. Bars and error bars represent means and standard errors for combined samples within a group (ICF1, ICF2, ICF3, ICF4 and WT) at seven chromosome ends (2p, 8p, 9p, 10p, 10q, 16p and 19p). To be noted: the y-axis is presented in a logarithmic scale. No significant differences in TERRA expression levels were apparent between ICF2, ICF3, ICF4 and WT groups. Significant differences in TERRA expression were only found between ICF1 and all other groups at subtelomeres 2p, 9p, 10p, 10q and 19p (P-value < 0.05, Welch's unequal variances t-test). P-values for comparisons between all groups appear in Figure S3A. (B) TERRA levels in ICF3 fibroblasts compared to ICF1 and WT fibroblasts. RNA was extracted from two ICF1 (1G, 1W), one ICF3 (3S) and two WT (W2, W6) fibroblast lines. For each telomere, TERRA expression in W2 was set at 1 and all other expression levels were determined relative to this sample. Bars and error bars represent means and standard errors of at least two experimental repeats for each sample within a group. To be noted: the y-axis is presented in a logarithmic scale. No significant differences were found between the WT group and ICF3 sample for any of the seven tested telomeres, while the ICF1 group differed significantly from both the WT group and ICF3 sample at all telomeres (P-value < 0.01, Welch's unequal variances t-test). P-values for all comparisons appear in Figure S3B .
subtypes, represent telomeres that barely express TERRA even in ICF1 cells. We could further demonstrate that ICF3 (3S) and WT (W2 and W6) fibroblasts expressed similar TERRA levels, while TERRA levels in ICF1 (1G and 1W) were significantly higher at all seven examined telomeres in comparison to WT and ICF3 (P-value < 0.01, Welch's unequal variances t-test, Figs. 3B and S3B). Considering that methylation of TERRA promoters is directly associated with TERRA repression (7,46), we can conclude that the normal low levels of TERRA in ICF2-4 cells indicate that these regions are highly methylated, at levels similar to those in control cells.
ICF 2-4 cells display normal telomere length
Abnormally short telomere length is a downstream consequence of subtelomeric hypomethylation in ICF1 cells that either express low levels of telomerase or completely lack telomerase expression (16, 17, 23, 44) . While not all telomeres shorten in ICF1 LCLs to the same degree (45) , telomeres as a group are substantially shorter in ICF1 in comparison to WT cells (17, 45) . To ascertain the general telomere-length status in ICF2-4, we performed terminal restriction fragment (TRF) analysis that reflects the status of many telomeres collectively. We first analyzed telomere length in WB samples obtained from several of the ICF1-4 patients (Fig. 4A) . None of the patient and control samples showed remarkably short telomere lengths. However, the average telomere length in the ICF1 patient (1G) appeared shorter in comparison to all other samples, with exception of sample 2D, which also demonstrated relatively short telomere lengths.
We proceeded to analyze telomere lengths in LCLs derived from patients and controls. As demonstrated previously (17, 45) , LCLs from ICF1 patients 1C and 1Y displayed very short telomere lengths (Fig. 4B) . All other LCLs showed average telomere lengths similar to those of the control LCLs, with the exception of ICF2 patient 2D who had shown relatively shorter telomere lengths in WB, as well. Interestingly, LCLs and WB of patient 2V, the brother of 2D, displayed normal average telomere lengths (Fig. 4A and  B) , suggesting the contribution of additional genetic modifiers to the differential telomere lengths in the two brothers.
To verify normal telomere length in ICF2-4 LCLs by an additional method we utilized telomere Fluorescence in situ (17) . Chromosome ends were scored for the occurrence of sister telomere loss (a signal missing from one sister chromatid-STL) or a signal free end (hybridization signals absent from both chromatids-SFE). The stacked plot shows the percentage of chromosome ends demonstrating STL and SFE hybridization patterns for each sample within a group. Hybridization patterns of all groups (ICF1, ICF2, ICF3, ICF4 and WT) were compared by χ 2 test for independence followed by post hoc multiple χ 2 tests with Benjamini/Hochberg correction (P-value < 0.0001). No significant difference was found between the WT and each of ICF2-4 groups. However, a significant difference was found between ICF1 and WT groups. hybridization (FISH), which allows inspection of all telomeres in a cell. When previously analyzed by this method, metaphases of ICF1 cells had telomere signals missing from many of their chromosome ends either from one sister chromatid (STL-sister telomere loss) or from both chromatids (SFE-signal free end) (17, 44) . To compare STLs and SFEs frequencies in ICF1 LCLs with those in ICF2-4 LCLs, we performed telomere-FISH on four ICF2-4 LCLs. Scoring of 800 chromosome ends for each sample (Fig. 4C) revealed that the percentage of STLs in ICF2-4 fell in the range detected previously for control LCLs (1.1-2.4%) (17) . The rate of SFEs in ICF2-4 LCLs was slightly elevated in our study (0.4-0.8%) compared to the rate in WT LCL (0-0.2%) (17) . However, when comparing chromosome ends with either STLs or SFEs, ICF2-4 displayed significantly lower frequencies in comparison to ICF1 (multiple χ 2 tests with Benjamin/Hochberg correction, P-value < 0.0001). The telomere FISH assay in this study was not used to determine the absolute telomere length, but rather for scoring the chromosome ends at which telomere length was too short to enable the detection of a hybridization signal. Taking this into account, we can conclude that despite the difference in the average telomere length in the LCLs derived from the two ICF2 brothers (2V and 2D), as detected by Southern analysis (Fig. 4A and B) , they do not differ in the rates of chromosome ends lacking telomeric signals (Fig. 4C) . Accelerated telomere shortening is associated with premature senescence in cells that do not express telomerase [reviewed in (47) ]. Accordingly, ICF1 fibroblasts enter senescence at a significantly low PD of between 5-45, depending on the patient, in comparison to 70 PDs in control fibroblasts (23, 44) . The two patient fibroblasts available, both from ICF3 patients (3C and 3S), were passaged for at least 45 PDs in culture, without showing signs of replicative senescence (results not shown).
When considering the combined data derived from the analyses of telomere length in ICF2-4 samples and the PD capacity of the ICF3 fibroblasts, we can infer that ICF2-4 cells display a normal range of telomere length.
Depletion of ICF2-4 related proteins does not alter subtelomeric methylation in normal fibroblasts
The normal subtelomeric methylation in ICF2-4 cells suggested that ZBTB24, CDCA7 and HELLS are dispensable for establishing or maintaining methylation at these regions. It was previously shown that pericentromeric methylation was significantly reduced as soon as 2 days following knockdown of Zbtb24, Cdca7 or Hells in mouse embryonic fibroblasts (MEFs) (28) , confirming that these genes are essential for maintaining methylation at mouse centromeric regions. To further clarify whether these gene products are necessary for maintaining human subtelomeric methylation, we followed a similar experimental approach as described (28) and transiently depleted ZBTB24, CDCA7, HELLS and DNMT3B from human normal fibroblasts by RNA interference. Forty eight hours following the siRNA treatment, we verified that <30% of protein product remained for each of the proteins (48) (Fig. S4 ) and continued to examine the effect of this knockdown on subtelomeric methylation. The transient knockdown of each of the four gene products did not alter the methylation levels at subtelomeric regions (Fig. 5A ), or at satellite 2 repeats (Fig. 5B) . Thus, in agreement with the findings in ICF2-4 patient cells, these data further indicate that ZBTB24, CDCA7 and HELLS, as well as DNMT3B, do not play a major role in maintaining subtelomeric methylation in human somatic cells, at least in the context of primary fibroblasts.
Discussion
Many highly repetitive sequences in mammalian genomes are hypomethylated in sperm and oocytes and undergo methylation by DNMT3B during implantation (49) (50) (51) . While the status of human subtelomeric repeats is unknown in oocytes, these regions were shown to be hypomethylated in sperm (6) . Their highly methylated status in human embryonic stem cells and iPSCs (52) suggests that they indeed undergo methylation during implantation. The majority of human subtelomeres are CpG rich and multiple human subtelomeres contain TERRA promoters that consist of CpG rich islands (7, 24) . However, in contrast to most CpG islands that are protected from de novo methylation during implantation [reviewed in (25, 26) ], human subtelomeric regions, including TERRA promoters, undergo methylation (17, 44) . The importance of this methylation for telomeric function can be inferred from the clear abnormal telomeric phenotype that arises when these regions remain hypomethylated, as found in ICF1 patient cells (16, 17, 23) . The telomeric phenotype in ICF1 includes abnormally high TERRA transcription, elevated DNA:RNA hybrids, abnormally short telomeres and premature replicative senescence (17, 23, 24, 44) . Although DNMT3B is the de novo DNMT implicated in the methylation of subtelomeres, it probably requires additional factors to be recruited to these regions [(53), reviewed in (54)]. Such factors may be expressed exclusively during early development, providing an explanation to the failure of wild type DNMT3B to restore subtelomeric methylation in ICF1 fibroblasts (23) . Further factors that participate in de novo methylation and/or support methylation maintenance of subtelomeres have not been identified yet.
ICF syndrome is a heterogeneous disease for which at least four genes are responsible (18) . Hypomethylation of pericentromeric repeats is a hallmark of all subtypes of ICF syndrome (21, 22) , while α-satellite repeats are exclusively hypomethylated in ICF2-4 (27, 38, 39) . The discovery that mutations in ZBTB24, CDCA7 or HELLS cause ICF syndrome, suggested that despite being devoid of DNMT activity, they participate in DNA methylation processes in human cells. Indeed, DNA profiling in ICF patients recently identified genomic regions that rely on the integrity of the four ICF factors for their methylation status, suggesting that ZBTB24, CDCA7 and HELLS could function as recruiting factors for DNMT3B at specific regions in the genome (48) . While only HELLS has been directly implicated in methylation establishment and maintenance in mice at centromeric satellite repeats and subtelomeric regions (33) , all three genes became attractive candidates as factors that participate in generating and/or maintaining human subtelomeric methylation.
Following this reasoning, we compared subtelomeric methylation and the telomeric phenotype in ICF2-4 cells with those of WT and ICF1 cells, the latter with an established abnormal phenotype at telomeres and subtelomeres. We were limited in the number of patient cells and the spectrum of mutations that we could examine due to the rarity of this syndrome. However, despite this limitation we can conclude that subtelomeric methylation, TERRA expression and telomere length are not globally disrupted in cells mutated in ZBTB24, CDCA7 or HELLS. This is true for WB and LCLs of ICF2-4 and fibroblasts of at least ICF3. To strengthen this conclusion, we knocked down the expression of the four genes responsible for ICF1-4 in human WT primary fibroblasts and found that the subtelomeric methylation was unperturbed, indicating that neither of these genes is essential for methylation maintenance at subtelomeres. Thus, our methylation analysis confirms that ZBTB24, CDCA7 and HELLS are not involved in establishment or in maintenance of human subtelomeric methylation. The RNA interference studies also demonstrated that in contrast to mouse minor satellite repeats (28) , methylation maintenance at human satellite 2 sequences does not rely on the integrity of ZBTB24, CDCA7 and HELLS. This may be explained by their different chromosomal position (centromeric versus pericentromeric) and their distinct chromatin landscapes (55, 56) , which may elicit different methylation maintenance mechanisms. Interestingly, depletion of DNMT3B was previously shown to reduce satellite 2 methylation in the HCT116 colon carcinoma cell line, suggesting a role for DNMT3B in methylation maintenance of these repeats (57) . However, our study did not reveal such methylation loss, perhaps pointing to a difference in methylation maintenance in transformed compared to primary non-transformed human cells.
Patients with different subtypes of ICF syndrome, demonstrate some clinical heterogeneity. Humoral immunodeficiency is more pronounced in ICF1 patients, while a higher incidence of Figure 5 . Subtelomeric methylation is unperturbed following transient knockdown of ZBTB24, CDCA7 and HELLs in normal human fibroblasts. Normal human W7 fibroblasts were subjected to siRNA knockdown of DNMT3B, (siDNMT3B), ZBTB24 (siZBTB24), CDCA7 (siCDCA7), HELLS (siHELLS) and a control siRNA (siCtrl). Bisulfite methylation analysis was performed on the siRNA-treated fibroblasts, as well as the non-transfected fibroblast cells (N.T.). The heat maps on the left indicate the relative methylation across (A) nine subtelomeric regions, and (B) satellite 2 repeats. In these maps, each amplicon consists of several lines, each line representing a specific CpG site, in the 5 to 3 direction of the sequence (top to bottom). The box plots on the right present the methylation percentage distribution of all CpG sites of (A) all subtelomeric amplicons, and (B) the satellite 2 amplicon, for each of the samples.
intellectual disability and a male bias are found in ICF2 (18, 58) . At the molecular level, the methylation status of α-satellite repeats separates ICF1 from the remaining subtypes, with type 1 maintaining relatively normal methylation levels, while the other subtypes demonstrate severe hypomethylation of these centromeric repeats (38, 39) . However, the abnormal methylation patterns in ICF syndrome are not restricted to repetitive regions alone (59) , and hypomethylation of several germline genes was found in blood of ICF1 patients, thus defining an additional ICF1-specific molecular signature in blood (21) . Likewise, genome-wide DNA methylation profiling clearly distinguishes patients with mutations in DNMT3B from those with mutations in ZBTB24, CDCA7 or HELLS (48) . The current study defines the subtelomeric methylation status as yet another molecular biomarker that distinguishes between ICF1 and the remaining subtypes of this syndrome.
In addition to high levels of DNA methylation, subtelomeric chromatin shares additional characteristics with centromeric and pericentromeric heterochromatin such as the H3K9me3 histone mark, histone H3 and H4 hypoacetylation and binding of heterochromatin protein 1 (60, 61) . Nevertheless, the subtelomeric hypomethylation that occurs only in ICF1, and the hypomethylation of α-satellite methylation found in all subtypes except ICF1, most probably reflect distinctive regulation, as well as specific cellular roles that these different heterochromatin regions play in mammalian cells. Therefore, disruption of heterochromatin at different genomic sites is expected to result in varying phenotypes. In this regard, several cases of cancer, a hallmark of telomere-mediated disorders (62) , have been reported in young ICF1 patients (58) . ICF1 patients, but not ICF2-4 patients, may be expected to display additional telomere related phenotypes such as premature aging of highly regenerative tissues during their lifetime, as described in diseases such as dyskeratosis congenita (63) . Up until recently, most ICF patients succumbed to disease before adulthood due to recurrent infections (64) . However, as bone marrow transplantation is becoming a more prevalent treatment for ICF syndrome patients (64, 65) , prolonged survival of ICF1 patients may lead to onset of premature senescence phenotypes such as aplastic anemia or pulmonary fibrosis, phenotypes characteristic of telomeropathies (62, 66) .
The previous finding that Hells plays a role in establishing subtelomeric methylation in mouse (33) , in contrast to our current findings that do not support a similar role for human HELLS, highlights the difference between mouse and human cells in the regulation of subtelomeric DNA methylation. Furthermore, human and mice respond differently to subtelomeric hypomethylation, with human cells demonstrating normal rates of telomere sister chromatid exchange (T-SCE) and an abnormal short telomere phenotype (17) , while in mice subtelomeric hypomethylation is associated with elevated T-SCE and abnormally long telomeres (67) . Whether or not impairment or absence of Zbtb24 and Cdca7 would affect mouse subtelomeric methylation is not known. Zbtb24 knockout mice have been generated (32) ; however, their subtelomeric methylation status has not been reported. Nevertheless, we can conclude that the telomeric phenotype in Dnmt3b and Hells-mutated mice does not mimic the telomeric phenotype in human cells that carry mutations in the homologous genes. The methylation maintenance at satellite repeats may also differ between human and mouse, as knocking down ZBTB24, CDCA7 and HELLS did not reduce satellite 2 methylation in normal human fibroblasts. This is in contrast to the observed loss of DNA methylation at centromeric minor satellite repeats in MEFs depleted for these factors (28) .
Aberrant methylation patterns at human subtelomeric regions are not restricted to ICF1 syndrome, as subtelomeric hypomethylation has been described also in a subset of human cancers that maintain telomeres by the alternative pathway (46, 68) . Similarly, hypomethylation of pericentromeric repeats is a hallmark of many cancers [reviewed in (69) ]. The findings in this study indicate that recruitment of DNMT3B to subtelomeric, pericentromeric or centromeric repeats is mediated by distinct factors. Uncovering these factors will unravel the molecular events that disrupt the epigenetic landscape at specific heterochromatin elements and clarify how these aberrations contribute to the abnormal phenotypes in genetic disease and tumorigenesis.
Materials and Methods
Patient samples and culture conditions
WB samples from patients and controls (Tables 1 and 2) were collected as described previously (21) . LCLs derived from patients with ICF1-4 syndrome (Table 1) were grown in RPMI supplemented with 20% fetal calf serum (FCS), 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Control WT LCLs GM08729 and GM119116c (Table 2) were grown in similar media as above, supplemented with 10% FCS. Primary fibroblasts from ICF1 and ICF3 patients (Table 1) were cultured in DMEM supplemented with 20% FCS, glutamine and antibiotics. Every 4-7 days, cells were subcultured to maintain a continuous log phase growth and the PD at each split was determined. Control WT FSE (70) and UN fibroblasts (71) ( Table 2) were grown under similar conditions, with 10% FCS.
Southern analyses of telomere length and methylation status
Purified genomic DNA was extracted according to standard procedures and subjected to restriction enzyme digestion and gel electrophoresis. After transferring DNA to a MagnaGraph nylon transfer membrane (Water and Process Technologies), the membrane was hybridized with the appropriate probe. For studying telomere length by TRF analysis, DNA was digested with HinfI or MspI, which both produce very similar TRFs. Analysis of subtelomeric methylation was carried out utilizing the Hutel subtelomeric-repeat probe following digestion with Sau3AI and MboI, each separately, as described (17) .
The methylation status of the centromeric NBL-1 and pericentromeric satellite 2 repeats was determined as described previously (17, 23) . The methylation status of satellite 3 repeats was determined by digestion of DNA with the restriction enzyme BstBI and hybridization with a satellite 3 oligonucleotide probe: 5 -CCATTCCATTCCAT/CTCGGGTT-3 (72) . The methylation status of α-satellite repeats was determined by digestion of DNA with the restriction enzyme HhaI and hybridization with an α-satellite oligonucleotide probe: 5 -ATGTGTGCATTCAACTCACA GAGTTGAAC-3 (21) . PCR products were purified by the QIAquick PCR purification kit (#28104, Qiagen). Additional amplicon processing, sequencing and analysis were performed as described (45) . Primers for amplification of subtelomeres were described previously (44) . Primers for satellite 2 amplification following bisulfite conversion were: Forward-5 -TGGAATTATTTTTTAATGGAAA-3 , Reverse-5 -TAAATAATTCCATTCG/AAATCC-3 (Chr1: 125,180,136-125,180,294 in Human GRCh38).
Methylation analysis by bisulfite sequencing
RNA extraction and quantitative RT-PCR (qRT-PCR)
RNA from patient LCLs and fibroblasts was extracted using the RNeasy Mini Kit (#74104, Qiagen). The purified RNA was treated with TURBO DNase (AM2238, Thermo Fisher Scientific) to eliminate any trace of DNA. One μg RNA was reverse transcribed at 55 • C using SuperScript III reverse transcriptase (Invitrogen), a β-actin-specific primer (5 -AGTCCGCCTAGAAGCATTTG-3 ) and a TERRA-specific primer composed from five telomere-hexameric repeats (CCCTAA) 5 , as described (73) . Expression levels of subtelomeric-specific TERRA and β-actin gene was determined by qRT-PCR using primers described previously (24) . qRT-PCR was done on an Applied Biosystems StepOnePlus Real-Time PCR system with Fast SYBR Green Master Mix (AB-4385612, Applied Biosystems). The delta delta Ct method using the β-actin as the reference gene (74) was utilized for the analyses.
Telomere-FISH
Metaphase spreads prepared from LCLs by standard procedures were hybridized with a PNA (CCCTAA) 3 oligo conjugated to Cy3, as described (75) . Approximately 800 chromosome ends were analyzed for each sample (from at least 10 metaphases). Normal hybridization signals at chromosome ends contain one signal per chromatid. We scored the percentage of chromosome ends with either a STL (one sister chromatid missing a signal) or a SFE (both sister chromatids lacking hybridization signals).
Knockdown of gene expression in primary skin fibroblasts
Knockdown of ZBTB24, CDCA7, HELLS and DNMT3B in WT human fibroblasts (designated W7 in this study) was carried out as described (48) . In short, two rounds of transfection with a mixture of three synthetic short interfering RNAs (siRNAs) per gene at a final concentration of 20 nM were performed using Lipofectamine RNAiMax Transfection Reagent (ThermoFisher Scientific) following the manufacturer's instructions: a first round on fibroblasts in suspension and the second round when cells were adhered to the plate. Cells were collected following 48 hours for genomic DNA, RNA and nuclear protein extractions. Sequences of siRNAs used to target ZBTB24, CDCA7 and HELLS, as well as a control siRNA, were described in (48) . Sequences of siRNA to target DNMT3B transcripts were as follows:
DNMT3B#1: 5 -GGCUGUUCAGCCAGCACUUUAAU-3 .
DNMT3B#2: 5 -UUUACCACCUGCUGAAUUA-3 .
DNMT3B#3: 5 -GCUCUUACCUUACCAUCGA-3 .
RNA and protein were subjected to qRT-PCR and western analysis to confirm the efficiency of the siRNA treatment, as described previously (48) . Primers for ZBTB24, CDCA7 and HELLS qRT-PCR were described previously (48) . qRT-PCR for DNMT3B was done using the following primers: Forward-5 -ATGAAGGGAGACACCAGGCATC-3 , Reverse-5 -CGAGCTTGAT CTTCGGCCTCTGAT-3 . Antibodies for western analysis of ZBTB24, CDCA7 and HELLS were described previously (48) . Western analysis of DNMT3B was carried out using an anti-DNMT3B (ab13604, Abcam) antibody. Subtelomeric methylation in samples following siRNA treatment was analyzed following bisulfite treatment, as described above.
Statistical analysis
All statistical analyses were conducted using python 2. 'Matplotlib'(1.5.1) was used for graphics. One-way ANOVA test was carried out to test variance of the mean methylation levels between samples (P-value < 0.0001). Tukey's HSD post hoc test was done to determine which sample pairs display a significant difference in methylation levels, with an adjusted P-value of <0.05 considered as significant. Pearson correlation test was used to determine the correlation between sample pairs in order to classify the samples into clusters. The two data vectors which served as the Pearson test inputs were comprised of methylation levels at all corresponding CpG positions in all corresponding subtelomeres of the two compared samples. Comparison of TERRA expression levels between samples was done using a t-test without assuming equal variance (Welch's unequal variances t-test). A χ 2 test was carried out for analysis of data obtained by telomere-FISH.
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